Lung Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Lung Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma [Phase 2]
Phase 2 study of LP-300 with carboplatin and pemetrexed in never-smokers with advanced lung adenocarcinoma; trial currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating TNG260 in combination with an anti-PD antibody in STK11-mutated solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating Me-4FDG PET/CT as an investigational imaging tracer for early detection of lung adenocarcinoma; cu…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %. [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the safety and potential efficacy of adding a short course of a MEK inhibitor to chemoimmunotherapy…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors [Phase 2]
Phase 2 study to assess safety and tolerability of PF-07220060 in adults with advanced solid tumors; the trial is currently ACTIVE_NOT_RECRU…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT [Phase 3]
A Phase 3 multicenter randomized trial compares segmentectomy versus lobectomy for 2–3 cm IASLC Grade 1–2 lung adenocarcinoma; recruitment n…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009) [NA]
This clinical trial entry describes a study evaluating sentinel lymph node dissection (SLND) versus no SLND in cT1 invasive lung adenocarcin…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma
A completed clinical trial update examining DNA methylation biomarkers to predict survival after surgical resection in patients with lung ad…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Comparison Paravertebral and Serratus Anterior Plane Block in Video-assisted Thoracoscopic Surgery. [NA]
Clinical trial comparing paravertebral block versus serratus anterior plane block for anesthesia in video-assisted thoracoscopic surgery in …
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Shared Decision Making in Patients With Lung Cancer
A clinical trial assessing shared decision making in patients diagnosed with lung adenocarcinoma undergoing surgery; the study is currently …
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer [Phase 2]
This entry covers the National Lung Matrix Trial, a multi-drug Phase II study in non-small cell lung cancer, with the trial currently active…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Sleep State in Lung Cancer: A Retrospective Analysis
A retrospective analysis evaluating sleep states and circadian rhythm disruptions in patients with lung cancer, including lung adenocarcinom…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Real-world Experience With Combination Chemotherapy and Osimertinib in Poor Prognostic Group of Metastatic EGFR-mutated Lung Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating the combination of chemotherapy with osimertinib in metastatic EGFR-mutated non-small cell lung cancer (lu…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors
This entry describes an ongoing clinical trial evaluating an MSLN-targeted PET imaging tracer for malignant tumors, with recruitment underwa…
-
CLINICAL_TRIALS research · 2025-01-21Clinical Trial Update: Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study [Phase 4]
Phase 4 multicenter real-world study evaluating the efficacy and safety of ensartinib as neoadjuvant therapy for stage IIA-IIIB ALK-positive…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Lymph Node Pathologic Grading Strategy
The document reports a clinical trial by Fudan University investigating a lymph node pathologic grading strategy for lung adenocarcinoma, wi…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma
This update notes a targeted therapy trial for patients with EGFR-mutant lung adenocarcinoma and that enrollment is by invitation.
-
CLINICAL_TRIALS research · 2024-10-21Clinical Trial Update: WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma
Clinical trial registry entry describing a study that uses whole slide image-based deep learning to diagnose the IASLC grading system in lun…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Retrospective Analysis of Clinical and CT Features to Predict Spread Through Air Space in Stage IA Lung Adenocarcinoma
Retrospective analysis examining clinical and CT features to predict spread through air space in Stage IA lung adenocarcinoma; the trial sta…
-
CLINICAL_TRIALS research · 2024-09-24Clinical Trial Update: Multi-omics Analysis to Characterize the Invasive Evolution of Pulmonary Subsolid Nodules
This update describes a multi-omics research study to characterize how pulmonary subsolid nodules evolve toward invasive adenocarcinoma.
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma [Phase 2]
Phase 2 trial evaluating adjuvant Benmelstobart for Stage IB, Grade 3 invasive lung adenocarcinoma (non-small cell lung cancer) is currently…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Parameter
This clinical trial aims to differentiate the invasiveness of lung adenocarcinoma using dual-energy CT parameters and is currently recruitin…
-
CLINICAL_TRIALS research · 2024-06-03Clinical Trial Update: Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012) [Phase 3]
A Phase 3 clinical trial (ECTOP-1012) evaluating segmentectomy for ground-glass-dominant invasive lung cancer is currently recruiting. The t…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Tumor Microenvironment
Clinical trial update from University Hospital Heidelberg for lung adenocarcinoma, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2018-04-03Clinical Trial Update: Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation [Phase 2]
Phase 2 clinical trial update evaluating gefitinib plus berberine as first-line therapy for EGFR-mutant lung adenocarcinoma.